Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia

被引:13
作者
Amundsen, Agot L.
Khoury, Janette
Sandset, Per M.
Seljeflot, Ingebjorg
Ose, Leiv
Tonstad, Serena
Henriksen, Tore
Retterstol, Kjetil
Iversen, Per O.
机构
[1] Univ Oslo, Dept Nutr, Inst Basic Med Sci, N-0316 Oslo, Norway
[2] Univ Oslo, Rikshosp, Dept Obstet & Gynecol, N-0027 Oslo, Norway
[3] Ullevaal Univ Hosp, Dept Hematol, Oslo, Norway
[4] Ullevaal Univ Hosp, Clin Res Ctr, Oslo, Norway
[5] Univ Oslo, Rikshosp, Lipid Clin, N-0027 Oslo, Norway
关键词
endothelium; familial hypepercholesterolemia; hemostasis; inflammation; pregnancy;
D O I
10.1016/j.thromres.2006.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Patients with familial hypercholesterolemia (FH) are prone to premature cardiovascular disease. During pregnancy plasma lipids reach higher absolute values in FH than in healthy women. Pregnancy is associated with activation of coagulation and possibly also of vascular endothelium, which might further increase the risk of cardiovascular disease in FH. However, whether hemostatic and endothelial activation markers are increased in pregnant FH women compared with non-FH pregnancies, is unknown. Materials and methods: Activation markers of hemostasis and endothelium were analyzed in blood samples collected prospectively from 22 heterozygous FH women during pregnancy and compared with those of a reference group of 149 healthy, pregnant women. Results: A procoagulant pattern was detected in both groups, but was more evident among FH women at least partly due to their enhanced thrombin generation, and because tissue factor pathway inhibitor type 1 increased in the reference group only. Furthermore, plasminogen activator inhibitor type 2 antigen increased more in FH than in the reference group. Whereas C-reactive protein, intercellular adhesion marker-1 and E-selectin did not change appreciably, vascular endothelial cell adhesion molecule 1 rose markedly in FH. Conclusion: Increased lipid levels as well as a net procoagulant activity and an enhanced endothelial activation possibly confer additional risks of cardiovascular disease among pregnant FH women. (c) 2006 Elsevier Ltd. All rights resented.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 24 条
[1]  
AMUNDSEN AL, 2006, IN PRESS ATHERO 0206
[2]   Familial hypercholesterolemia and coronary heart disease: A HuGE association review [J].
Austin, MA ;
Hutter, CM ;
Zimmern, RL ;
Humphries, SE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (05) :421-429
[3]   A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1 [J].
Bendz, B ;
Andersen, TO ;
Sandset, PM .
THROMBOSIS RESEARCH, 2000, 97 (06) :463-472
[4]   Pregnancy related changes in some cardiovascular risk factors [J].
Berge, LN ;
Arnesen, E ;
Forsdahl, A .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1996, 75 (05) :439-442
[5]   Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women [J].
Bombeli, T ;
Raddatz-Mueller, P ;
Fehr, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (03) :382-389
[6]   Haemostatic changes in pregnancy [J].
Brenner, B .
THROMBOSIS RESEARCH, 2004, 114 (5-6) :409-414
[7]   Relation between maternal recreational physical activity and plasma lipids in early pregnancy [J].
Butler, CL ;
Williams, MA ;
Sorensen, TK ;
Frederick, IO ;
Leisenring, WM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (04) :350-359
[8]   Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia [J].
Civeira, F .
ATHEROSCLEROSIS, 2004, 173 (01) :55-68
[9]   Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis [J].
Dahm, A ;
Vlieg, AV ;
Bendz, B ;
Rosendaal, F ;
Bertina, RM ;
Sandset, PM .
BLOOD, 2003, 101 (11) :4387-4392
[10]  
Defesche JC, 2000, LIPIDS VASCULAR DIS, P65